Announcements Trials

Browse Landscape

Phase

Phase 4 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 Stomach Neoplasms 3 Neoplasms 3 Head and Neck Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Peritoneal Neoplasms 2 Margins of Excision 2 Colorectal Neoplasms 2 Sarcoma 1 Right Hemicolectomy 1 Ovarian Neoplasms 1 Lymphedema 1 Lung Neoplasms 1 Endometrial Neoplasms 1 Colonic Neoplasms 1 Cholecystitis 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Breast Cancer Lymphedema 1

Interventions

Doxorubicin 62 Ifosfamide 39 Gemcitabine 29 Radiotherapy 27 Filgrastim 27 Cyclophosphamide 26 Docetaxel 19 Vincristine 18 pembrolizumab 17 Etoposide 17 pazopanib 16 Cisplatin 16 Nivolumab 15 Trabectedin 14 apatinib 13 Magnetic Resonance Spectroscopy 13 Carboplatin 12 Irinotecan 11 Bevacizumab 11 anlotinib 10 Temozolomide 10 Surgical Procedures, Operative 10 Sirolimus 10 camrelizumab 9 Sorafenib 9 Paclitaxel 9 Ipilimumab 9 Injections 9 Dactinomycin 9 Topotecan 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Sarcoma × Indocyanine Green × Clear all

NCT04719156 2026-02-20

ICGTM

University of Pittsburgh

Phase 2 Recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡